{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:02Z","timestamp":1787725802351,"version":"build-2784847793"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>\n                    Reliable differentiation of Parkinson\u2019s disease\/Lewy body dementia (PD\/LBD) from frontotemporal dementia (FTD) affects treatment strategy and clinical trial eligibility, yet confirmatory biomarker testing remains costly and unevenly available. Whether routine cognitive trajectories can support testing prioritization has not been systematically quantified. We performed a progressive inclusion analysis of 1,129 National Alzheimer\u2019s Coordinating Center participants with PD\/LBD (\n                    <jats:italic>n<\/jats:italic>\n                    = 385) or FTD (\n                    <jats:italic>n<\/jats:italic>\n                    = 744) to determine the minimum number of serial Montreal Cognitive Assessment (MoCA) administrations required for diagnostic separation. Random forest classifiers used seven MoCA subdomain slopes from the first k chronological assessments (\n                    <jats:italic>k<\/jats:italic>\n                    = 2 through\n                    <jats:italic>k<\/jats:italic>\n                    = 8), with five-fold stratified cross-validation and 500-iteration bootstrap confidence intervals. In the primary full-cohort analysis, two assessments yielded AUC = 0.785 (95% CI 0.757\u20130.814; sensitivity = 0.922; specificity = 0.525). The interval-restricted 6\u201312 month subset yielded AUC = 0.837 (95% CI 0.787\u20130.885), near the lower edge of published biomarker-panel ranges in an indirect comparison, although its lower confidence bound remained below 0.85. Discrimination persisted after age matching (AUC = 0.794, 95% CI 0.761\u20130.826; residual age gap = \u22120.3 years) and age restriction to 55\u201375 years (AUC = 0.777, 95% CI 0.741\u20130.814). Age alone yielded lower discrimination (AUC = 0.721, 95% CI 0.691\u20130.751) than MoCA slopes, while slopes plus age yielded AUC = 0.867 (95% CI 0.845\u20130.888). Four-assessment performance was AUC = 0.831 (95% CI 0.791\u20130.873), consistent with an apparent sample-size-limited plateau as eligible N contracted from 391 at\n                    <jats:italic>k<\/jats:italic>\n                    = 4 to 98 at\n                    <jats:italic>k<\/jats:italic>\n                    = 6. These findings support serial MoCA trajectory analysis as an exploratory tool for prioritizing confirmatory diagnostic testing, with age sensitivity, subtype sensitivity, and operating-point performance quantified.\n                  <\/jats:p>","DOI":"10.3389\/fnagi.2026.1848105","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:19Z","timestamp":1787723839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Two serial MoCA assessments may support biomarker-sparing triage between Parkinson\u2019s disease\/Lewy body dementia and frontotemporal dementia: a progressive inclusion analysis of 1,129 participants"],"prefix":"10.3389","volume":"18","author":[{"given":"Wei","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic","place":["Jacksonville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet S.","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic","place":["Jacksonville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic","place":["Jacksonville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for alzheimer\u2019s trial selection and disease monitoring.","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00702-016-1517-6","article-title":"MMSE and MoCA in Parkinson\u2019s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study","volume":"123","author":"Biundo","year":"2016","journal-title":"J. Neural. Transm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: Appropriate use recommendations.","volume":"10","author":"Cummings","year":"2023","journal-title":"J. Prev. Alzheimers Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants.","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1679649","DOI":"10.3389\/fnins.2026.1679649","article-title":"Enhanced diagnostic interpretation of the MoCA using machine learning.","volume":"20","author":"Gourdeau","year":"2026","journal-title":"Front. Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The alzheimer\u2019s association appropriate use recommendations for blood biomarkers in alzheimer\u2019s disease.","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1704039","DOI":"10.3389\/fnagi.2025.1704039","article-title":"Machine learning methods for the detection and prediction of cognitive impairment in parkinson\u2019s disease: A systematic review and meta-analysis.","volume":"17","author":"Jiang","year":"2025","journal-title":"Front. Aging Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with lewy bodies: Fourth consensus report of the DLB consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with lewy bodies.","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: A cross-sectional study.","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"key":"B14","volume-title":"Global Status Report On The Public Health Response To Dementia.","year":"2021"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1848105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:20Z","timestamp":1787723840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1848105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":14,"alternative-id":["10.3389\/fnagi.2026.1848105"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1848105","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1848105"}}